Skip to main content
SpringerLink
Log in

Nutritional Influences on Hormonal Health

  • Chapter
  • First Online:
Integrative and Functional Medical Nutrition Therapy

  • 2559 Accesses

Abstract

A systematic approach to regulating hormones is outlined within. The steps in the process for hormone balancing will be reviewed as they build upon each other. Hormones must be balanced and working in concert with one another to maintain good health. Many factors affect hormonal balance, such as food quality and poor nutrition, stress, and environmental toxins. Unfortunately, we live in an increasingly toxic world and these exposures affect our endocrine system and hormonal balance. These toxic exposures include the air we breathe, the food we eat, the water we drink, and even the thoughts we think. Endocrine active chemicals (EACs) or endocrine disruptors can cause variations in normal hormone function. Even small alterations in hormone concentrations have significant and lasting effects. Further, some EACs have the potential to impact human health at lower doses than limits set in traditional toxicity testing by regulatory agencies, which means that some effects may be overlooked.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Application of Systematic Review Methods in an Overall Strategy for Evaluating Low-Dose Toxicity from Endocrine Active Chemicals. Committee on Endocrine-Related Low-Dose Toxicity; Board on Environmental Studies and Toxicology; Division on Earth and Life Studies; National Academies of Sciences, Engineering, and Medicine, 2017. http://nap.edu/24758.

  2. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1–4.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ludwig DS, Ebbeling CB. Type 2 diabetes mellitus in children: primary care and public health considerations. JAMA. 2001;286(12):1427–30.

    Article  CAS  PubMed  Google Scholar 

  4. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693–700.

    Article  PubMed  Google Scholar 

  5. Hyman M. The blood sugar solution: the Ultrahealthy program for losing weight, preventing disease, and feeling great now! 1st ed. New York: Little, Brown and Company; 2012. p. 7–10.

    Google Scholar 

  6. Tuomikoski P, Savolainen-Peltonen H. Vasomotor symptoms and metabolic syndrome. Maturitas. 2017;97:61–5.

    Article  CAS  PubMed  Google Scholar 

  7. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005;47(4):201–10.

    CAS  PubMed  Google Scholar 

  8. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–7. https://doi.org/10.1242/dmm.001180.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T et al, Israeli Diabetes Research Group. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med. 2005;353(14):1454–62.

    Google Scholar 

  10. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. Obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–24.

    Article  PubMed  Google Scholar 

  11. Pfutzner A, Weber MM, Forst T. A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus. Clin Lab. 2008;54(11–12):485–90.

    PubMed  Google Scholar 

  12. Gabriel CL, Smith PB, Mendez-Fernandez YV, Wilhelm AJ, Ye AM, Major AS. Autoimmune-mediated glucose intolerance in a mouse model of systemic lupus erythematosus. Am J Physiol Endocrinol Metab. 2012;303(11):E1313–24. https://doi.org/10.1152/ajpendo.00665.2011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Fasano A. Surprises from celiac disease. Sci Am. 2009;301(2):54–61.

    Article  CAS  PubMed  Google Scholar 

  14. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al. Glycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322(7277):15–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ahuja V, Kadowaki T, Evans RW, Kadota A, Okamura T, El Khoudary SR, Fujiyoshi A, Barinas-Mitchell EJ, Hisamatsu T, Vishnu A, Miura K, Maegawa H, El-Saed A, Kashiwagi A, Kuller LH, Ueshima H, Sekikawa A, ERA JUMP Study Group. Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study. Diabetologia. 2015;58(2):265–71. https://doi.org/10.1007/s00125-014-3414-6.

    Article  PubMed  Google Scholar 

  16. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–95. https://doi.org/10.2337/diacare.27.6.1487.

    Article  PubMed  Google Scholar 

  17. Stern JH, Rutkowski JM, Scherer PE. Adiponectin, Leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab. 2016 May 10;23(5):770–84. https://doi.org/10.1016/j.cmet.2016.04.011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Fragopoulou E, Panagiotakos DB, Pitsavos C, Tampourlou M, Chrysohoou C, Nomikos T, Antonopoulou S, Stefanadis C. The association between adherence to the Mediterranean diet and adiponectin levels among healthy adults: the ATTICA study. J Nutr Biochem. 2010 Apr;21(4):285–9. https://doi.org/10.1016/j.jnutbio.2008.12.013.

    Article  CAS  PubMed  Google Scholar 

  19. Chaput JP, Tremblay A, Rimm EB, Bouchard C, Ludwig DS. A novel interaction between dietary composition and insulin secretion: effects on weight gain in the Quebec Family Study. Am J Clin Nutr. 2008;87(2):303–9.

    Article  CAS  PubMed  Google Scholar 

  20. Davis DR, Epp MD, Riordan HD. Changes in USDA food composition data for 43 garden crops, 1950 to 1999. J Am Coll Nutr. 2004;23(6):669–82.

    Article  CAS  PubMed  Google Scholar 

  21. Luo Z, Zhang Y, Li F, He J, Ding H, Yan L, et al. Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells. Endocrine. 2009;36(1):60–9.

    Article  CAS  PubMed  Google Scholar 

  22. McGarry JD. Glucose-fatty acid interactions in health and disease. Am J Clin Nutr. 1998;67(3 Suppl):500S–4S.

    Article  CAS  PubMed  Google Scholar 

  23. Meydani M. A Mediterranean-style diet and metabolic syndrome. Nutr Rev. 2005;63(9):312–4.

    Article  PubMed  Google Scholar 

  24. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano GD, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–6.

    Article  CAS  PubMed  Google Scholar 

  25. USDA National Agriculture Library: nutrient changes over time: frequently asked questions. [Internet 2017]. Available from: http://www.nal.usda.gov/fnic/faq.

  26. Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr. 2009;89(4):1037–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Upadhyay S, Dixit M. Role of polyphenols and other phytochemicals on molecular signaling. Oxid Med Cell Longev. 2015, Article ID 504253, 15 pages. https://doi.org/10.1155/2015/504253.

  28. Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 1999;13(3):203–8.

    Article  CAS  PubMed  Google Scholar 

  29. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002;56(11):1137–42.

    Article  CAS  PubMed  Google Scholar 

  30. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med. 1999;27(3–4):309–14.

    Article  CAS  PubMed  Google Scholar 

  31. Haak E, Usadel KH, Kusterer K, Amini P, Frommeyer R, et al. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes. 2000;108(3):168–74.

    Article  CAS  PubMed  Google Scholar 

  32. Chiu KC, Chu A, Go VL. Saad MF Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820–5.

    Article  CAS  PubMed  Google Scholar 

  33. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Asp Med. 2003;24(1–3):39–52.

    Article  CAS  Google Scholar 

  34. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004;30:253–8.

    Article  CAS  PubMed  Google Scholar 

  35. Kim CW, Kim BT, Park KH, Kim KM, Lee DJ, Yang SW, et al. Effects of short-term chromium supplementation on insulin sensitivity and body composition in overweight children: randomized, double-blind, placebo-controlled study. J Nutr Biochem. 2011;22(11):1030–4.

    Article  CAS  PubMed  Google Scholar 

  36. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society Scientific Statement. Endocr Rev. 2009;30940:293–342. https://doi.org/10.1210/er.2009-0002.

    Article  CAS  Google Scholar 

  37. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, Vom Saal FS. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology. 2012;153(9):4097–110. https://doi.org/10.1210/en.2012-1422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Alonso-Magdalena P, Quesada I, Nadal A. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol. 2011;7(6):346–53.

    Article  CAS  PubMed  Google Scholar 

  39. Kim KN, Park SJ, Choi B, Joo NS. Blood mercury and insulin resistance in nondiabetic Koreans (KNHANES 2008-2010). Yonsei Med J. 2015;56(4):944–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA. Nathan DM; diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  CAS  PubMed  Google Scholar 

  41. WHO: Global Strategy on Diet, Physical Activity and Health. Physical activity and adults. [Internet 2018]. Accessed 12/22/2018: https://www.who.int/dietphysicalactivity/factsheet_adults/en/.

  42. Klein S, Sheard NF, Pi-Sunyer X, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the north American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004;80(2):257–63.. Review

    Article  CAS  PubMed  Google Scholar 

  43. Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F, Goldberg J, Vaccarino V. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J. 2008;156(4):759.el–7.

    Article  Google Scholar 

  44. Kataoka M, Ito C, Sasaki H, Yamane K, Kohno N. Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes. Diabetes Res Clin Pract. 2004;64(1):51–8.

    Article  PubMed  Google Scholar 

  45. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32(Suppl 1):S62–7. https://doi.org/10.2337/dc09-S062.

    Article  PubMed Central  Google Scholar 

  46. Aldabal L, Bahammam AS. Metabolic, endocrine, and immune consequences of sleep deprivation. Open Respir Med J. 2011;5:31–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Goodman HM. Chapter 4 – adrenal glands. In: Basic medical endocrinology. 4th ed. Elsevier; 2009. p. 61–90. https://doi.org/10.1016/B978-0-12-373975-9.X0001-8

  48. Jackson M. Chapter 1 Evaluating the role of Hans Selye in the modern history of stress. In: Cantor D, Ramsden E, editors. Stress, shock, and adaptation in the twentieth century: Rochester Studies in Medical History. Rochester: University of Rochester Press; 2014.

    Google Scholar 

  49. Brady KT, Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. A J Psych. Published Online: 1 Aug 2005. https://doi.org/10.1176/appi.ajp.162.8.1483.

  50. McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2009;1032(1):1–7. https://doi.org/10.1196/annals.1314.001.

    Article  Google Scholar 

  51. A to Z Guide: WebMD. Adrenal fatigue: is it real? [Internet WebMD Medical Reference Reviewed by William Blahd, MD on January 23, 2017]. Accessed 12/28/2018. https://www.webmd.com/a-to-z-guides/adrenal-fatigue-is-it-real#1.

  52. Evans PJ, Peters JR, Dyas J, Walker RF, Riad-Fahmy D, Hall R. Salivary cortisol levels in true and apparent hypercortisolism. Clin Endocrinol. 1984;20(6):709–15.

    Article  CAS  Google Scholar 

  53. Peters JR, Walker RF, Riad-Fahmy D, Hall R. Salivary cortisol assays for assessing pituitary-adrenal reserve. Clin Endocrinol. 1982;17(6):583–92.

    Article  CAS  Google Scholar 

  54. Mccabe D, Colbeck M. The effectiveness of essential fatty acid, B vitamin, vitamin C, magnesium and zinc supplementation for managing stress in women: a systematic review protocol. JBI Database System Rev Implement Rep. 2015;13(7):104–18.

    Article  PubMed  Google Scholar 

  55. Vinogradov V, Shneider A, Senkevich S. Thiamine cardiotropism. Cor Vasa. 1991;33(3):254–62.

    CAS  PubMed  Google Scholar 

  56. Nakagawasai O, Yamadera F, Iwasaki K, Arai H, Taniguchi R, Tan-No K, et al. Effect of kami-untan-to on the impairment of learning and memory induced by thiamine-deficient feeding in mice. Neuroscience. 2004;125(1):233–41.

    Article  CAS  PubMed  Google Scholar 

  57. Peters EM, Anderson R, Nieman DC, Fickl H, Jogessar V. Vitamin C supplementation attenuates the increases in circulating cortisol, adrenaline and anti-inflammatory polypeptides following Ultramarathon running. Int J Sports Med. 2001;22(7):537–43.

    Article  CAS  PubMed  Google Scholar 

  58. Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J Am Coll Nutr. 1994;13(5):429–46.

    Article  CAS  PubMed  Google Scholar 

  59. Delarue J, Matzinger O, Binnert C, Schneiter P, Chioléro R, Tappy L. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab. 2003;29(3):289–95.

    Article  CAS  PubMed  Google Scholar 

  60. Moriguchi T, Greiner RS, Salem N. Behavioral deficits associated with dietary induction of decreased brain Docosahexaenoic acid concentration. J Neurochem. 2008;75(6):2563–73.

    Article  Google Scholar 

  61. Hutchins H, Vega C. Omega-3 fatty acids: recommendations for therapeutics and prevention. MedGenMed. 2005;7(4):18.

    PubMed  Google Scholar 

  62. Zwart SR, Mehta SK, Ploutz-Snyder R, et al. Response to Vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein-Barr virus reactivation. J Nutr. 2011;141(4):692–7.

    Article  CAS  PubMed  Google Scholar 

  63. Human Vitamin and Mineral Requirements. Ch. 16 Zinc: zinc metabolism and homeostasis. FAO/WHO-FAO Corporate Document Repository. Retrieved 6-9-15 from http://www.fao.org/docrep/004/y2809e/y2809e0m.htm

  64. Deans E. Zinc: an antidepressant, the essential mineral for resiliency. Psychology Today: Evolutionary Psychiatry. 2013. Accessed: https://www.psychologytoday.com/us/blog/evolutionary-psychiatry/201309/zinc-antidepressant

  65. Prasad A. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009;12(6):646–52.

    Article  CAS  PubMed  Google Scholar 

  66. Frederickson CJ, et al. Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr. 2000;130(5):1471S–83S.

    Article  CAS  PubMed  Google Scholar 

  67. Yoshida E, Fukuwatari T, Ohtsubo M, Shibata K. High-fat diet lowers the nutritional status indicators of pantothenic acid in weaning rats. Biosci Biotechnol Biochem. 2010;74(8):1691–3.

    Article  CAS  PubMed  Google Scholar 

  68. Jaroenporn S, Yamamoto T, Itabashi A, et al. Effects of pantothenic acid supplementation on adrenal steroid secretion from male rats. Biol Pharm Bull. 2008;31(6):1205–8.

    Article  CAS  PubMed  Google Scholar 

  69. Panossian A, Wikman G, Kaur P, Asea A. Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine. 2009;16(6–7):617–22.

    Article  CAS  PubMed  Google Scholar 

  70. Panossian A, Wikman G, Kaur P, Asea A. Adaptogens stimulate neuropeptide Y and Hsp72 expression and release in neuroglia cells. Front Neurosci. 2012;6:6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Morales J, et al. Effects of replacement dose of DHEA in men and women of advancing age. J Clin Endo Metab. 1994;78(6):1360–7.

    CAS  Google Scholar 

  72. Vallée M, et al. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res Brain Res Rev. 2001;37(1–3):301–12.

    Article  PubMed  Google Scholar 

  73. Zhai G, et al. Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet. 2011;7(4):e1002025. https://doi.org/10.1371/journal.pgen.1002025.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Ross DS. Thyroid hormone synthesis and physiology. Up to date [Internet February 23, 2018]. Accessed 12/20/2018: https://www.uptodate.com/contents/thyroid-hormone-synthesis-and-physiology.

  75. Surks MI. Clinical manifestations of hypothyroidism. Up to Date. [Internet October 31, 2018]. Accessed 12/28/2018: https://www.uptodate.com/contents/clinical-manifestations-of-hypothyroidism.

  76. Lauritano EC, Bilotta AL, Gabrielli M, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab. 2007;92:4180.

    Article  CAS  PubMed  Google Scholar 

  77. Berger MM, et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med. 2001;27(1):91–100.

    Article  CAS  PubMed  Google Scholar 

  78. Olivieri O, et al. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res. 1996;51(1):31–41.

    Article  CAS  PubMed  Google Scholar 

  79. Bremner AP, et al. Significant association between thyroid hormones and erythrocyte indices in euthyroid subjects. Clin Endocrinol. 2012;76(2):304–11.

    Article  CAS  Google Scholar 

  80. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid. 2002;12(10):867–78.

    Article  CAS  PubMed  Google Scholar 

  81. Eftekhari MH, et al. Effect of iron repletion and correction of iron deficiency on thyroid function in iron-deficient Iranian adolescent girls. Pak J Biol Sci. 2007;10(2):255–60.

    Article  CAS  PubMed  Google Scholar 

  82. Howdeshell KL. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect. 2002;110(Suppl 3):337–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Kivity S, et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol. 2011;8(3):243–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Feart C, et al. Aging affects the retinoic acid and the triiodothyronine nuclear receptor mRNA expression in human peripheral blood mononuclear cells. Eur J Endocrinol. 2005;152(3):449–58.

    Article  CAS  PubMed  Google Scholar 

  85. Kwon DH, Lee JH, Ryu KJ, Park HT, Kim T. Vasomotor symptoms and the homeostatic model assessment of insulin-resistance in Korean postmenopausal women. Obstet Gynecol Sci. 2016;59(1):45–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of Estrogen plus progestin in healthy postmenopausal women principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33. https://doi.org/10.1001/jama.288.3.321.

    Article  Google Scholar 

  87. Lobo RA. Where are we 10 years after the Women's Health Initiative? J Clin Endocrinol Metabol. 2013;98(5):1771–80. https://doi.org/10.1210/jc.2012-4070.

    Article  CAS  Google Scholar 

  88. Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view. J Steroid Biochem Mol Biol. 2014;142:4–11.

    Article  CAS  PubMed  Google Scholar 

  89. Chang JL, Montalto MB, Heger PW, Thiemann E, et al. Rettenberger R, Rheum rhaponticum extract (ERr 731): Postmarketing data on safety surveillance and consumer complaints. Integr Med (Encinitas). 2016;15(3):34–9.

    Google Scholar 

  90. Castro B, Sánchez P, Torres JM, Preda O, del Moral RG, Ortega E. Bisphenol A exposure during adulthood alters expression of aromatase and 5α-reductase isozymes in rat prostate. PLoS One. 2013;8(2).

    Google Scholar 

  91. Joensen UN, Veyrand B, Antignac JP, Blomberg Jensen M, Petersen JH, Marchand P, Skakkebæk NE, Andersson AM, Le Bizec B, Jørgensen N. PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. Hum Reprod. 2013;28(3):599–608. https://doi.org/10.1093/humrep/des425. Epub 2012 Dec 18. Erratum in: Hum Reprod. 2014 Jul;29(7):1600.

    Article  CAS  PubMed  Google Scholar 

  92. Stephensen K, et al. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors, cardiovascular biomarkers, quality – of-life measures; and health outcomes in postmenopausal women. Int J Pharm Compd. 2013;17(1):74–85.

    Google Scholar 

  93. Santen R, et al. Postmenopausal hormone therapy: an Endocrine Society Scientific Statement. JCEM. 2010;95(1):7.

    Google Scholar 

  94. Simon JA. What’s new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone. Climacteric. 2012;15(Suppl 1):3–10.

    Article  CAS  PubMed  Google Scholar 

  95. Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005;114(3):448–54.

    Article  CAS  PubMed  Google Scholar 

  96. Casanova G, Spritzer PM. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial. Lipids Health Dis. 2012;11:133.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Morgantaler A, et al. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224–51.

    Article  CAS  Google Scholar 

  98. L'hermite M, Simoncini T, Fuller S, Genazzani AR. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review Maturitas. 2008;60(3–4):185–201.

    Article  CAS  PubMed  Google Scholar 

  99. Roemheld-Hamm B. Chasteberry. American Family Physician. [Internet September 1, 2005]. Accessed 1/12/2019: https://www.aafp.org/afp/2005/0901/p821.html.

  100. Romm A. Balance your hormones: 5 ways vitex can help your hormones. [Internet October 27, 2018]. Accessed 1/12/2019: https://avivaromm.com/vitex-hormones/.

  101. Warren MP, Ramos RH. Chapter 32 – Alternative therapies to hormone replacement therapy. In: Lobo RA, Kelsey J, Marcus R. Menopause: biology and pathobiology. Academic Press; 2000. p. 459–80. https://doi.org/10.1016/B978-012453790-3/50033-0.

  102. Kaszkin-Bettag M, Richardson A, Rettenberger R, Heger PW. Long-term toxicity studies in dogs support the safety of the special extract ERr 731 from the roots of Rheum rhaponticum. Food Chem Toxicol. 2008;46(5):1608–18.

    Article  CAS  PubMed  Google Scholar 

  103. Kaszkin-Bettag M, Beck S, Richardson A, Heger PW, Beer AM. Efficacy of the special extract ERr 731 from rhapontic rhubarb for menopausal complaints: a 6-month open observational study. Altern Ther Health Med. 2008;14(6):32–8.

    PubMed  Google Scholar 

  104. Hasper I, Ventskovskiy BM, Rettenberger R, Heger PW, Riley DS, Kaszkin-Bettag M. Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms. Menopause. 2009;16(1):117–31.

    Article  PubMed  Google Scholar 

  105. Kaszkin-Bettag M, Ventskovskiy BM, Kravchenko A, Rettenberger R, Richardson A, et al. The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal women. Menopause. 2007;14(2):270–83.

    Article  PubMed  Google Scholar 

  106. Wober J, Möller F, Richter T, Unger C, Weigt C, et al. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds. J Steroid Biochem Mol Biol. 2007;107(3–5):191–201.

    Article  CAS  PubMed  Google Scholar 

  107. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 2010;119(2):463–474.

    Google Scholar 

  108. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, et al. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 2006;1766(1):63–78.

    CAS  PubMed  Google Scholar 

  109. Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann N Y Acad Sci. 2006;1089:286–301.

    Article  CAS  PubMed  Google Scholar 

  110. Cavalieri EL, Rogan EG. Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention. Clin Transl Med. 2016;5(1):12.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Saudade Wellness, Capitola, CA, USA

    Filomena Trindade

Authors
  1. Filomena Trindade
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Filomena Trindade .

Editor information

Editors and Affiliations

  1. Noland Nutrition, Burbank, CA, USA

    Diana Noland

  2. Professor Emeritus, School of Medicine, University of Kansas Health System, Kansas City, KS, USA

    Jeanne A. Drisko

  3. Department of Dietetics & Nutrition, University of Kansas Medical Center, Kansas City, KS, USA

    Leigh Wagner

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Trindade, F. (2020). Nutritional Influences on Hormonal Health. In: Noland, D., Drisko, J., Wagner, L. (eds) Integrative and Functional Medical Nutrition Therapy. Humana, Cham. https://doi.org/10.1007/978-3-030-30730-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-30730-1_31

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-30729-5

  • Online ISBN: 978-3-030-30730-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation